# 바이오스페이스 일일 뉴스 리포트 - 2025년 12월 21일


## 주요 헤드라인

1. **Kyowa Kirin Could Get Windfall From Updated Newborn Screening Recommendations (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/kyowa-kirin-could-get-windfall-from-updated-newborn-screening-recommendations>

2. **Kyowa Kirin Could Get Windfall From Updated Newborn Screening Recommendations (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/kyowa-kirin-could-get-windfall-from-updated-newborn-screening-recommendations>

3. **BioMarin Pumps Up Revenue Goals With $4.8B Amicus Purchase (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/biomarin-pumps-up-revenue-goals-with-4-8b-amicus-purchase>

4. **BioMarin Pumps Up Revenue Goals With $4.8B Amicus Purchase (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/biomarin-pumps-up-revenue-goals-with-4-8b-amicus-purchase>

5. **Cytokinetics’ Moment of Truth (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/cytokinetics-moment-of-truth-can-aficamten-take-on-bms-in-hypertrophic-cardiomyopathy>

6. **Insmed Delivers ‘Rare Disappointment’ as Brinsupri Flops in Mid-Stage Rhinosinusitis Study (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/insmed-delivers-rare-disappointment-as-brinsupri-flops-in-mid-stage-rhinosinusitis-study>

7. **Patient Deaths Put Merck, Daiichi Sankyo’s Antibody-Drug Conjugate on Hold (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/patient-deaths-put-merck-daiichi-sankyos-antibody-drug-conjugate-on-hold>


---
*2025년 12월 21일 바이오스페이스 뉴스 피드에서 생성된 리포트*